These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 2649012

  • 1. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD, Horiguchi Y, Couchman JR.
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [Abstract] [Full Text] [Related]

  • 2. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa.
    Fine JD.
    Arch Dermatol; 1990 Sep; 126(9):1187-90. PubMed ID: 2396835
    [Abstract] [Full Text] [Related]

  • 3. Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa.
    Fine JD, Holbrook KA, Elias S, Anton-Lamprecht I, Rauskolb R.
    Prenat Diagn; 1990 Apr; 10(4):219-29. PubMed ID: 2195497
    [Abstract] [Full Text] [Related]

  • 4. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa.
    Fine JD, Breathnach SM, Hintner H, Katz SI.
    J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168
    [Abstract] [Full Text] [Related]

  • 5. Chondroitin 6-sulfate proteoglycan but not heparan sulfate proteoglycan is abnormally expressed in skin basement membrane from patients with dominant and recessive dystrophic epidermolysis bullosa.
    Fine JD, Couchman JR.
    J Invest Dermatol; 1989 Apr; 92(4):611-6. PubMed ID: 2522973
    [Abstract] [Full Text] [Related]

  • 6. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
    Heagerty AH, Kennedy AR, Leigh IM, Purkis P, Eady RA.
    Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
    [Abstract] [Full Text] [Related]

  • 7. Ultrastructural findings in epidermolysis bullosa.
    Smith LT.
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [Abstract] [Full Text] [Related]

  • 8. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
    Kennedy AR, Heagerty AH, Ortonne JP, Hsi BL, Yeh CJ, Eady RA.
    Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455
    [Abstract] [Full Text] [Related]

  • 9. Prenatal diagnosis of dominant and recessive dystrophic epidermolysis bullosa: application and limitations in the use of KF-1 and LH 7:2 monoclonal antibodies and immunofluorescence mapping technique.
    Fine JD, Eady RA, Levy ML, Hejtmancik JF, Courtney KB, Carpenter RJ, Holbrook KA, Hawkins HK.
    J Invest Dermatol; 1988 Nov; 91(5):465-71. PubMed ID: 3049834
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a functional defect of the lamina lucida in recessive dystrophic epidermolysis bullosa demonstrated by suction blisters.
    Tidman MJ, Eady RA.
    Br J Dermatol; 1984 Oct; 111(4):379-87. PubMed ID: 6487542
    [Abstract] [Full Text] [Related]

  • 11. Ultrastructure and molecular pathogenesis of epidermolysis bullosa.
    Shinkuma S, McMillan JR, Shimizu H.
    Clin Dermatol; 2011 Oct; 29(4):412-9. PubMed ID: 21679868
    [Abstract] [Full Text] [Related]

  • 12. Detection and partial characterization of a midlamina lucida-hemidesmosome-associated antigen (19-DEJ-1) present within human skin.
    Fine JD, Horiguchi Y, Jester J, Couchman JR.
    J Invest Dermatol; 1989 Jun; 92(6):825-30. PubMed ID: 2656873
    [Abstract] [Full Text] [Related]

  • 13. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa.
    Fine JD, Gay S.
    Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588
    [Abstract] [Full Text] [Related]

  • 14. Expression of integrins in junctional and dystrophic epidermolysis bullosa.
    Nazzaro V, Berti E, Cerri A, Brusasco A, Cavalli R, Caputo R.
    J Invest Dermatol; 1990 Jul; 95(1):60-4. PubMed ID: 1694890
    [Abstract] [Full Text] [Related]

  • 15. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD.
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [Abstract] [Full Text] [Related]

  • 16. Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa.
    McMillan JR, McGrath JA, Tidman MJ, Eady RA.
    J Invest Dermatol; 1998 Feb; 110(2):132-7. PubMed ID: 9457907
    [Abstract] [Full Text] [Related]

  • 17. Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa.
    Phillips RJ, Aplin JD, Lake BD.
    Histopathology; 1994 Jun; 24(6):571-6. PubMed ID: 8063286
    [Abstract] [Full Text] [Related]

  • 18. Mutation analysis and molecular genetics of epidermolysis bullosa.
    Pulkkinen L, Uitto J.
    Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
    [Abstract] [Full Text] [Related]

  • 19. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
    Rao R, Mellerio J, Bhogal BS, Groves R.
    Indian J Dermatol Venereol Leprol; 2012 Feb; 78(6):692-7. PubMed ID: 23075637
    [Abstract] [Full Text] [Related]

  • 20. A specific defect in glycosylation of epidermal cell membranes. Definition in skin from patients with epidermolysis bullosa simplex.
    Fine JD, Griffith RD.
    Arch Dermatol; 1985 Oct; 121(10):1292-6. PubMed ID: 2412497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.